APVO — Aptevo Therapeutics Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-07-20.
Performance
Technicals
Others in Healthcare
Measured signals that fired on APVO
| date | signal | measured base rate |
|---|---|---|
| 2026-07-30 | Short volume far above its own normal short | -0.76% over 21 days · t = -2.79 · n = 5,897 statistically distinguishable from its control group |
| 2026-03-20 | Short volume far above its own normal short | -0.76% over 21 days · t = -2.79 · n = 5,897 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-08-06 | White Marvin L Executive Chair | Shares withheld for tax | 406 | 4.07 | 1.7K |
| 2026-08-06 | Huebner Dirk SVP, CMO | Shares withheld for tax | 156 | 4.07 | 635 |
| 2026-08-06 | Kunz Barbara Lopez Director | Option exercise | 400 | — | — |
| 2026-08-06 | White Marvin L Executive Chair | Option exercise | 1.7K | — | — |
| 2026-08-06 | Huebner Dirk SVP, CMO | Option exercise | 638 | — | — |
| 2026-08-06 | Grant Grady III Director | Option exercise | 400 | — | — |
| 2026-08-06 | Niederhuber John Director | Option exercise | 400 | — | — |
| 2026-08-06 | Abdun-Nabi Daniel Director | Option exercise | 400 | — | — |
| 2026-08-06 | Kwon SoYoung SVP, GC, BD & Corp Affairs | Option exercise | 638 | — | — |
| 2026-08-06 | Taylor Daphne SVP, CFO | Option exercise | 638 | — | — |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 56.9K | 13.3K |
| VANGUARD CAPITAL MANAGEMENT LLC | 54.3K | 12.7K |
| VANGUARD FIDUCIARY TRUST CO | 17.7K | 4.1K |
| UBS Group AG | 14.7K | 3.4K |
| OSAIC HOLDINGS, INC. | 1.5K | 360 |
| SBI Securities Co., Ltd. | 465 | 109 |
| GSA CAPITAL PARTNERS LLP | 84 | 19.6K |
| CWM, LLC | 21 | 5 |
| DANSKE BANK A/S | 4 | 1 |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| SCHEDULE 13G/A | 2026-08-14 | — | on EDGAR ↗ |
| 10-Q | 2026-08-14 | 2026-06-30 | on EDGAR ↗ |
| 8-K | 2026-08-14 | 2026-08-14 | on EDGAR ↗ |
| 8-K | 2026-08-13 | 2026-08-12 | on EDGAR ↗ |
| 4 | 2026-08-10 | 2026-08-06 | on EDGAR ↗ |
| 4 | 2026-08-10 | 2026-08-06 | on EDGAR ↗ |
| 4 | 2026-08-10 | 2026-08-06 | on EDGAR ↗ |
| 4 | 2026-08-10 | 2026-08-06 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Aptevo Therapeutics Inc. (APVO) filed form 8-K · 2026-08-21 · SEC EDGAR
- Aptevo Therapeutics Inc. (APVO) filed form 8-K · 2026-08-14 · SEC EDGAR
- Aptevo Therapeutics reports Q2 results · 2026-08-14
- Aptevo Therapeutics Inc. (APVO) filed form SCHEDULE 13G/A · 2026-08-14 · SEC EDGAR
- Aptevo Therapeutics Inc. (APVO) filed form 10-Q · 2026-08-14 · SEC EDGAR
- Aptevo Therapeutics Inc. (APVO) filed form 8-K · 2026-08-14 · SEC EDGAR
Ask the AI about APVO
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →